{"id":"NCT01794923","sponsor":"Pfizer","briefTitle":"Topical Ibuprofen for Delayed Onset Mulscle Soreness","officialTitle":"PLACEBO-CONTROLLED, DOUBLE-BLIND EVALUATION OF THE EFFICACY AND SAFETY OF IBUPROFEN 5% TOPICAL GEL FOR THE TREATMENT OF DELAYED-ONSET MUSCLE SORENESS OF THE ELBOW FLEXOR MUSCLES","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-06-13","primaryCompletion":"2014-03-29","completion":"2014-03-29","firstPosted":"2013-02-20","resultsPosted":"2021-09-30","lastUpdate":"2021-09-30"},"enrollment":205,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain"],"interventions":[{"type":"DRUG","name":"IBU BID","otherNames":[]},{"type":"DRUG","name":"Placebo BID","otherNames":[]},{"type":"DRUG","name":"IBU TID","otherNames":[]},{"type":"DRUG","name":"Placebo TID","otherNames":[]}],"arms":[{"label":"Ibuprofen 5% topical gel BID","type":"EXPERIMENTAL"},{"label":"Placebo topical gel BID","type":"PLACEBO_COMPARATOR"},{"label":"Ibuprofen 5% topical gel TID","type":"EXPERIMENTAL"},{"label":"Placebo topical gel TID","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study is to compare the efficacy and safety of Ibuprofen 5% Topical Gel versus placebo administered two or three times daily for the treatment of pain associated with delayed onset muscle soreness following intense eccentric exercise of the elbow flexor muscles.","primaryOutcome":{"measure":"Change From Baseline in the Time-Weighted Sum of Muscle Soreness With Movement Over 0-24 Hours Post-Dose 1 (MSM 0-24 )","timeFrame":"Baseline, 0 to 24 hours post-Dose 1 on Day 1","effectByArm":[{"arm":"Placebo Combined","deltaMin":22.2,"sd":4.46},{"arm":"Ibuprofen Twice Daily","deltaMin":17.8,"sd":5.12},{"arm":"Ibuprofen Three Times Daily","deltaMin":29.7,"sd":5}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":"0.200"},{"comp":"OG000 vs OG002","p":"0.230"},{"comp":"OG000 vs OG001","p":"0.484"},{"comp":"OG001 vs OG002","p":"0.077"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B3491010&StudyName=Topical%20Ibuprofen%20for%20Delayed%20Onset%20Mulscle%20Soreness"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":83},"commonTop":["Erythema","Dry skin"]}}